<DOC>
	<DOCNO>NCT01153620</DOCNO>
	<brief_summary>The primary objective study assess antiseptic efficacy Lavasept 0.04 % use antiseptic agent compare Ringers ' solution patient acute traumatic wound .</brief_summary>
	<brief_title>The Antiseptic Efficacy Tolerability Lavasept® 0.04 % Acute Traumatic Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<mesh_term>Polyhexamethylene biguanide</mesh_term>
	<criteria>Patients acute traumatic cut , crush , abrasion , bite stab wound Provision voluntary consent participate study , follow full explanation nature purpose study , sign informed consent form approve Institutional Ethics Committee ( IEC ) prior evaluation Wounds minimum approximately 4 cm2 size Ability read understand German patient information sheet informed consent form &lt; 18 year age Pregnancy Immunosuppression Wounds cause burn Wounds require treatment hyaline cartilage , central nervous system , peritoneum , meningae , inner / middle ear inner eye Simultaneous participation another clinical trial Wounds require immediate surgical medical treatment well patient critically ill Patient known allergy active agent excipients Wounds &gt; 3 cm depth Wounds receive medical treatment ≥6 hour Heavily bleed wound Open fracture , joint tendon Wounds face</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Acute traumatic wound</keyword>
</DOC>